1. Home
  2. ALTI vs ALLO Comparison

ALTI vs ALLO Comparison

Compare ALTI & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALTI
  • ALLO
  • Stock Information
  • Founded
  • ALTI 2020
  • ALLO 2017
  • Country
  • ALTI United States
  • ALLO United States
  • Employees
  • ALTI N/A
  • ALLO N/A
  • Industry
  • ALTI Investment Managers
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ALTI Finance
  • ALLO Health Care
  • Exchange
  • ALTI Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • ALTI 302.7M
  • ALLO 338.9M
  • IPO Year
  • ALTI N/A
  • ALLO 2018
  • Fundamental
  • Price
  • ALTI $3.26
  • ALLO $1.45
  • Analyst Decision
  • ALTI
  • ALLO Strong Buy
  • Analyst Count
  • ALTI 0
  • ALLO 10
  • Target Price
  • ALTI N/A
  • ALLO $9.66
  • AVG Volume (30 Days)
  • ALTI 128.4K
  • ALLO 3.1M
  • Earning Date
  • ALTI 05-09-2025
  • ALLO 05-12-2025
  • Dividend Yield
  • ALTI N/A
  • ALLO N/A
  • EPS Growth
  • ALTI N/A
  • ALLO N/A
  • EPS
  • ALTI N/A
  • ALLO N/A
  • Revenue
  • ALTI $206,935,000.00
  • ALLO $22,000.00
  • Revenue This Year
  • ALTI $25.79
  • ALLO N/A
  • Revenue Next Year
  • ALTI $9.88
  • ALLO $9.07
  • P/E Ratio
  • ALTI N/A
  • ALLO N/A
  • Revenue Growth
  • ALTI N/A
  • ALLO N/A
  • 52 Week Low
  • ALTI $2.33
  • ALLO $1.23
  • 52 Week High
  • ALTI $5.45
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • ALTI 55.89
  • ALLO 43.61
  • Support Level
  • ALTI $2.75
  • ALLO $1.33
  • Resistance Level
  • ALTI $3.40
  • ALLO $1.53
  • Average True Range (ATR)
  • ALTI 0.28
  • ALLO 0.14
  • MACD
  • ALTI 0.06
  • ALLO 0.02
  • Stochastic Oscillator
  • ALTI 82.05
  • ALLO 64.71

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: